Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis

Mod Rheumatol Case Rep. 2021 Jan;5(1):141-144. doi: 10.1080/24725625.2020.1775991. Epub 2020 Jun 18.

Abstract

An 84-year-old Japanese woman suffering from rheumatoid arthritis (RA), who had been treated with methotrexate (MTX) for 15 years, was admitted to our hospital for generalised lymphadenopathy, thrombocytopenia, anaemia, elevated aminotransferases, and elevated CRP levels. Pathological findings of cervical lymph node biopsy were compatible with histiocytic necrotising lymphadenitis (HNL). Small lymphocytes positive for Epstein-Barr virus (EBV)-encoded small RNA were detected in the tissue. We suspected a MTX-associated lymphoproliferative disorder (MTX-LPD), withdrew MTX and administered leucovorin (folic acid). The patient's symptoms gradually resolved following discontinuation of MTX. We considered that this patient developed HNL as an MTX-LPD when EBV was reactivated. This is the first case of HNL associated with MTX treatment for RA, which we report here along with clinical course.

Keywords: Epstein-Barr virus (EBV); Methotrexate-associated lymphoproliferative disorder (MTX-LPD); histiocytic necrotising lymphadenitis (HNL); lymphoma; rheumatoid arthritis (RA).

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Arthritis, Rheumatoid / drug therapy
  • Biopsy
  • Female
  • Herpesvirus 4, Human / genetics*
  • Histiocytic Necrotizing Lymphadenitis / chemically induced*
  • Histiocytic Necrotizing Lymphadenitis / pathology
  • Humans
  • Lymph Nodes / pathology
  • Lymphoproliferative Disorders / chemically induced*
  • Lymphoproliferative Disorders / pathology
  • Methotrexate / adverse effects*

Substances

  • Methotrexate